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Abstract
Background: Early detection and treatment of neonatal hyperbilirubinemia is important in the prevention of
bilirubin-induced encephalopathy. In this study, we evaluated the New Jersey pediatricians' practices and beliefs
regarding the management of neonatal hyperbilirubinemia and their compliance with the recommendations made
by the American Academy of Pediatrics (AAP) in 1994.
Methods: A survey questionnaire was mailed to a random sample of 800 pediatricians selected from a list of 1623
New Jersey Fellows of the AAP initially in October 2003 and then in February 2004 for the non-respondents. In
addition to the physicians' demographic characteristics, the questionnaire addressed various aspects of neonatal
hyperbilirubinemia management including the diagnosis, treatment, and follow up as well as the pediatricians'
beliefs regarding the significance of risk factors in the development of severe hyperbilirubinemia.
Results: The adjusted response rate of 49.1% (n = 356) was calculated from the 725 eligible respondents. Overall,
the practicing pediatricians reported high utilization (77.9%) of the cephalocaudal progression of jaundice and low
utilization (16.1%) of transcutaneous bilirubinometry for the quantification of the severity of jaundice. Most of the
respondents (87.4%) identified jaundice as an indicator for serum bilirubin (TSB) testing prior to the neonate's
discharge from hospital, whereas post-discharge, only 57.7% felt that a TSB was indicated (P < 0.01). If the
neonate's age was under 72 hours, less than one-third of the respondents reported initiation of phototherapy at
TSB levels lower than the treatment parameters recommended by the AAP in 1994, whereas if the infant was
more than 72 hours old, almost 60% were initiating phototherapy at TSB lower than the 1994 AAP guidelines.
Most respondents did not regard neonatal jaundice noted after discharge and gestational ages 37–38 weeks as
being significant in the development of severe hyperbilirubinemia. However, the majority did recognize the
importance of jaundice presenting within the first 24 hours and Rh/ABO incompatibility.
Conclusion:  The pediatricians' practices regarding the low utilization of laboratory diagnosis for the
quantification of jaundice after discharge and underestimation of risk factors that contribute to the development
of severe hyperbilirubinemia are associated with initiation of phototherapy at lower than AAP recommended
treatment parameters and recognition of neonatal hyperbilirubinemia as an important public health concern.
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Background
Management of hyperbilirubinemia remains a challenge
for neonatal medicine because of the risk for serious neu-
rological complications related to the toxicity of bilirubin
[1]. The neonatal hyperbilirubinemia practice guidelines
published in 2004 by the American Academy of Pediatrics
(AAP) expresses the pediatric community's concern
regarding bilirubin-induced neurological pathology [2].
The prevention of bilirubin encephalopathy is based on
the detection of infants at risk for developing significant
hyperbilirubinemia and the early treatment of this condi-
tion [3]. Newman and Maisels [4] have questioned the
compliance with the existing guidelines in the neonatal
hyperbilirubinemia cases associated with an adverse out-
come. Therefore, understanding the pediatricians' prac-
tices and beliefs towards the management of neonatal
hyperbilirubinemia is of particular importance. A survey
conducted more than ten years ago showed wide variation
in neonatal hyperbilirubinemia management practices
among the pediatricians and neonatologists [5]. Approxi-
mately 66% of the pediatricians reported an awareness of
the neonatal hyperbilirubinemia clinical practice guide-
lines published in 1994 [6]. Atkinson et al [7] showed that
only 54% of the pediatricians initiated treatment in
accord with the recommended parameters [7]. However,
none of the previous studies investigated the pediatri-
cians' preferences regarding management of hyperbiliru-
binemia in term infants before and after hospital
discharge. Moreover, no study has clearly assessed the
pediatricians' beliefs regarding the risk factors for severe
neonatal hyperbilirubinemia.
In the present survey study we evaluated the New Jersey
pediatricians' practices and beliefs regarding management
of neonatal hyperbilirubinemia and their compliance
with the 1994 AAP recommendations.
Methods
We designed a mailing survey study. The survey question-
naire was mailed to a random sample of 800 pediatricians
selected from a list of 1623 New Jersey Fellows of the AAP.
The list obtained from the AAP did not specify the physi-
cians' area of practice. The questionnaire was mailed twice
to the pediatricians, initially in 2003 (October 27–29)
and then in 2004 (February 24–28) for the non-respond-
ents. A letter that assured the participants of the voluntary
nature of the study, complete anonymity, and confidenti-
ality of data accompanied the questionnaire.
All respondents were classified as those: (i) who com-
pleted more than 80% of questions; (ii) who completed
50% to 80% of questions; (iii) who did not return survey;
and (iv) others (questionnaire returned by postal services
for the non-availability of a forwarding address). The cat-
egories that were not eligible for inclusion in the analysis
included: residents in training; retired pediatricians; pedi-
atricians who did not provide services for newborn
infants; and pediatricians who answered less than 50% of
the questions. The technique of the Council of American
Survey Research Organization (CASRO) was used to clas-
sify the survey respondents and calculate the response rate
[8].
Study Instrument
We designed a two-page (four-sided) survey question-
naire that included 25 questions. The questions addressed
various aspects of neonatal hyperbilirubinemia manage-
ment such as pre-discharge bilirubin testing and follow up
of infants who were jaundiced at discharge, the diagnostic
and treatment approaches used for the management of
neonatal hyperbilirubinemia, and the public health sig-
nificance of these conditions. The physicians were also
asked about their practice type, the population area cov-
ered by their service, years in practice since completing
residency, annualized number of neonates seen in their
practice, and experience with cases of kernicterus.
All questions were designed using a yes/no and either sin-
gle or multiple-choice format. A scale type format (hardly
at all, to a small degree, to a moderate degree, to a very
high degree, and not applicable) was used to assess the
pediatrician's beliefs regarding the risk factors for severe
hyperbilirubinemia. We assessed the following risk fac-
tors: jaundice presenting in first 24 hours, jaundice noted
at discharge, previous siblings with jaundice, gestational
age between 37 and 38 weeks, breast feeding, bruising/
cephalohematoma, Rh and ABO incapability, and glu-
cose-6-phosphate dehydrogenase (G-6-PD) deficiency).
We asked the pediatricians questions regarding the hour-
specific TSB (at 25–48 hours, 49–72 hours and >72
hours) that they used for the initiation of phototherapy
and/or exchange transfusion, and the TSB they considered
as high risk for the development of kernicterus in term
neonates. We also asked about diagnostic approaches
(transcutaneous bilirubinometry, cephalocaudal progres-
sion), and pre- and post-discharge neonatal hyperbiliru-
binemia management. Additionally, we sought their
opinion on whether severe hyperbilirubinemia and ker-
nicterus should be considered a public health concern and
made reportable conditions in the New Jersey.
The questionnaire was pre-tested among seven pediatri-
cians from the university hospital and private practice set-
ting in order to reduce redundancy and increase the clarity
of the questions. The Institutional Review Board of the
UMDNJ-Robert Wood Johnson Medical School approved
the study.BMC Pediatrics 2006, 6:6 http://www.biomedcentral.com/1471-2431/6/6
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Statistical analysis
The statistical analysis was performed using STATISTICA
6.0 for Windows (StatSoft, Inc., Tulsa, OK) to identify the
significance of the observed differences in proportion
(Chi-square test) and the continuous variables (analysis
of variance).
We reported results for the overall sample and for groups
that were determined by the type of pediatric practice
(university hospital, community hospital, private group,
and private solo). Age-specific total serum bilirubin (TSB)
levels published by the AAP in 1994 for the initiation of
phototherapy and/or exchange transfusion were used for
assessment of the pediatricians' preference in the treat-
ment of neonatal jaundice [9]. Significant differences
were accepted if the P value was less than 0.05 (2-tailed).
Results
Response rate and demographic characteristic of the 
respondents
Among the 431 returned questionnaires, 24 were received
incomplete from retired pediatricians, 13 from pediatri-
cians in residency training, and 17 from pediatricians who
did not provide neonatal services. Twenty-one question-
naires were returned because of lack of a forwarding
address. The rest of the respondents (n = 356) completed
more than 84% of the survey questions and were included
in the analysis. The adjusted response rate of 49.1% was
calculated by dividing the number of completed survey
questionnaires (n = 356) by the 725 eligible responders
[800-(24+13+17+21)].
The majority of the respondents (90.7%, n = 323/356)
were board certified. The demographic and practice char-
acteristics of pediatricians by the type of practice are pre-
sented in Table 1. Most of the respondents practiced in
private groups and provided services for children from the
suburban area of New Jersey. University and community
hospital-based practices that most often provided pediat-
ric services for children from urban and rural areas
involved only 19.9% of the respondents. Private pediatri-
cians in solo practice were older, had been in practice
much longer and provided services for a lesser annual
number of neonates.
Pediatricians' practice preference for neonatal 
hyperbilirubinemia management
Overall, a higher proportion of pediatricians checked TSB
levels in jaundiced neonates prior to their discharge from
the hospital as compared to jaundiced neonates noticed at
the infant's post-discharge visit (87.4% vs. 57.7, P < 0.01).
Table 2 indicates that pediatricians from the university
hospitals showed lower TSB testing activity prior to the
jaundiced neonate's discharge from the hospital as com-
pared to pediatricians in private practice. In cases where
the mother called for advice regarding the baby's jaundice,
the majority of pediatricians asked the mother to bring the
infant to the office and only 12% of them preferred to
directly refer the infant to a laboratory in order to obtain
a TSB level. None of the pediatricians advised the mother
to stop breastfeeding. Most respondents used cephalocau-
dal progression of jaundice and a significantly low
number of pediatricians (mainly in solo practice) used
transcutaneous bilirubinometry (TcB) for the quantifica-
tion of neonatal jaundice.
Treatment pattern of neonatal hyperbilirubinemia
Pediatricians' practices regarding phototherapy use in
neonates with respect to age-specific TSB levels are
revealed in Figure 1. Initiation of phototherapy at TSB lev-
els lower than recommended by the AAP at 24–48 (≥15
mg/dL), 49–72 (≥18 mg/dL), and >72 hours (≥20 mg/dL)
Table 1: Demographic and other characteristics of the pediatricians by the type of practice
Characteristics Type of Practice
Total* 
(n = 356)
University Hospital 
(n = 29)
Community 
Hospital (n = 42)
Private Group 
(n = 219)
Private Solo 
(n = 66)
P** value
Male 175(49.2%) 18(62.1%) 16(38.1%) 105(47.9%) 36(55.4%) .108
Age (years) † 45.3 ± 11.5 39.9 ± 12.8 43.3 ± 10.9 45.4 ± 10.8 49.8 ± 12.7 .01
Years after residency* 14.3 ± 1.4 11.3 ± 9.8 12.1 ± 10.1 14.6 ± 9.3 16.5 ± 9.8 .05
Neonates per year†† 150 245 300 170 60 .01
Practice area***
Suburban 302(84.5%) 20(69.0%) 24(57.1%) 203(92.7%) 55(83.3%) .01
Urban 110(30.9%) 19(65.5%) 27(64.3%) 44(20.1%) 20(30.3%) .01
Rural 56(15.7%) 5(17.2%) 11(26.2%) 33 (15.1%) 7(10.6%) .07
* Total number of respondents (University and Community Hospitals, Private Groups and Solo)
** P-values represent Chi-square test (for proportion) and analysis of variance (for continuous variables)
*** Check all that apply
† Mean age ± Standard Deviation (years)
†† MedianBMC Pediatrics 2006, 6:6 http://www.biomedcentral.com/1471-2431/6/6
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were reported by 21.8%, 26.4% and 57.2% of the pedia-
tricians, respectively. As shown in Figure 2, exchange
transfusions at TSB levels lower than recommended by
AAP at the age of 24–48 (≥20 mg/dL), 49–72 (≥25 mg/
dL), and >72 hours (≥25 mg/dL) were reported by 6.7%,
32.7%, and 34.2% of the respondents, respectively. The
pediatrician's preference for using age-specific thresholds
of TSB for phototherapy and exchange transfusion was
not associated with the type of practice.
Risk factors for hyperbilirubinemia and kernicterus
The pediatricians' response regarding risk factors for the
development of severe neonatal hyperbilirubinemia is
presented in Table 3. The majority believed "to a very high
or moderate degree" that jaundice presenting in the first
24 hours and Rh/ABO incompatibility were significant
risk factors for the development of hyperbilirubinemia in
term infants. More than 70% of the pediatricians stated
that "hardly ever or to a small degree" would they con-
sider gestational age between 37–38 weeks and jaundice
noted after discharge from the hospital as significant risk
factors for the development of severe neonatal hyperbi-
lirubinemia. Breast-feeding, bruising/cephalohematoma,
and previous siblings with jaundice were rated by more
than 80% of pediatricians' as risk factors for hyperbiliru-
binemia with only a small or moderate degree of belief.
The pediatricians' belief regarding the relationship
Table 2: Pediatricians' preferences regarding the management of neonatal jaundice
Practice Type
Total* University 
Hospital
Community 
Hospital
Private Group Private Solo P** 
value
TSB testing with clinical jaundice before discharge 306/350 (87.4%) 16/24 (66.7%) 39/42 (92.9%) 195/218 (89.5%) 55/64 (85.9%) 0.012
TSB testing with clinical jaundice post-discharge 196/340 (57.7%) 12/24 (50.0%) 28/37 (75.7%) 116/214 (54.2%) 39/64 (60.9%) 0.302
Using cephalocaudal assessment† 271/348 (77.9%) 21/28 (75.0%) 34/41 (82.9%) 170/217 (78.3%) 46/62 (74.2%) 0.645
Using TcB assessment† 56/349 (16.1%) 5/27 (18.5%) 10/42 (23.8%) 34/216 (15.7%) 7/64 (10.9%) 0.017
Recommendations to the mother regarding the 
baby's jaundice
1. Bring baby to the office 284/335 (84.8%) 20/25 (80%) 35/40 (87.5%) 175/210 (83.3%) 53/60 (88.3%) 0.426
2. Put baby in the sunlight 3/335 (1.1%) - 1/40 (2.5%) 2/210 (0.95%) -
3. Refer baby for TSB measurement 38/335 (11.4%) 3/25 (12.0% 3/40 (7.5%) 26/210 (12.4%) 6/60 (10.0%)
4. Stop breastfeeding - - - - -
5. Other 9/335 (2.7%) 2/25 (8.0%) - 7/210 (3.3%) 1/60 (1.7%)
*Total number of respondents (University and Community Hospitals, Private Groups and Solo)
** P-values represent Chi-square test (for proportion)
†To quantify the severity of jaundice
The proportion of pediatricians who practiced phototherapy  treatment for term infants in accord with the AAP recom- mended [9] hour-specific TSB levels (mg/dL) at 25–48 hours  (≥15 mg/dL), 49–72 hours (≥18 mg/dL), and >72 hours (≥20  mg/dL) Figure 1
The proportion of pediatricians who practiced phototherapy 
treatment for term infants in accord with the AAP recom-
mended [9] hour-specific TSB levels (mg/dL) at 25–48 hours 
(≥15 mg/dL), 49–72 hours (≥18 mg/dL), and >72 hours (≥20 
mg/dL).
The proportion of pediatricians who practiced exchange  transfusion if intensive phototherapy fails for term infants in  accord with the AAP recommended [9] hour-specific TSB  levels (mg/dL) at 25–48 hours (≥20 mg/dL), 49–72 hours  (≥25 mg/dL), and >72 hours (≥25 mg/dL) Figure 2
The proportion of pediatricians who practiced exchange 
transfusion if intensive phototherapy fails for term infants in 
accord with the AAP recommended [9] hour-specific TSB 
levels (mg/dL) at 25–48 hours (≥20 mg/dL), 49–72 hours 
(≥25 mg/dL), and >72 hours (≥25 mg/dL).BMC Pediatrics 2006, 6:6 http://www.biomedcentral.com/1471-2431/6/6
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between these risk factors and severe hyperbilirubinemia
was not associated with the practice type.
Only 48 of the 351 respondents (13.9%) reported first
hand experience with one or more patients with ker-
nicterus. These pediatricians were older (50.7+/-11.5 vs.
44.5+/-11.3 years, P < 0.03) and had been in practice
much longer (18.0+/-12.4 vs. 13.8 +/-12.4 years, P < 0.01)
as compared those who had not seen a single case of ker-
nicterus. A large number of pediatricians believed that a
TSB more than 20 mg/dL was a significant risk factor for
the development of kernicterus (Figure 3). Among these,
a higher proportion of pediatricians from community
hospitals regarded bilirubin >30 mg/dL as a risk factor for
kernicterus. The vast majority of respondents (more than
88% in each practice group) rated kernicterus as a public
health concern and about 50% agreed that severe hyperbi-
lirubinemia and kernicterus should be made laboratory
based reportable conditions in New Jersey.
Discussion
The result of our population-based survey of practicing
pediatricians in New Jersey showed overall uniformity
with the 1994 AAP recommendations [9] in the manage-
ment of neonatal hyperbilirubinemia prior to discharge
but significant heterogeneity in the post-discharge follow
up and treatment practices. Although the majority of
respondents preferred to see infants with jaundice in their
office, most did not consider post-discharge jaundice as
an indicator for a follow up TSB level. Such post-discharge
follow up practices may contribute to the development of
undiagnosed pathological neonatal hyperbilirubinemia
because of the practice of early discharge and the presen-
tation of jaundice mostly after the third day of life [10,11].
However, almost all of the respondents were concerned
about bilirubin-induced neurological complications and
recognized the importance of post-discharge TSB moni-
toring. Therefore, the lack of outcome expectancy that is
often classified as the major factor influencing physicians'
compliance with existing recommendations [12] could
not be considered. In addition, approximately 60% of the
pediatricians reported the initiation of phototherapy in
neonates more than 72 hours old at TSB levels lower than
recommended by the AAP [9]. Gartner et al (although the
age of the infants was not reported) previously revealed
this general tendency for the initiation of phototherapy at
lower TSB levels in a pediatrician's survey in 1992 [5].
Concern has been expressed regarding negative outcome
in association with the use of lower threshold bilirubin
levels for the initiation of therapy for neonates with
hyperbilirubinemia [13-15]. The initiation of photother-
apy at TSB lower than the AAP recommended levels by
some pediatricians may reflect the insufficiency in our
understanding of the biology of neonatal jaundice [16].
Table 3: Pediatricians' answers to the question: "Do you believe that following factors are associated with severe hyperbilirubinemia in 
term neonates?"
Risk factor and number of respondents Response
Hardly at all To a small degree To a moderate 
degree
To a very high 
degree
Not applicable
Jaundice presenting in the first 24 hours (n = 348) 2.3% 3.5% 17.2% 77.0% -
Jaundice noted at discharge (n = 345) 14.2% 52.5% 29.3% 2.9% 1.2%
Gestational age between 37 and 38 weeks (n = 346) 25.1% 45.7% 26.0% 2.0% 1.2%
Breastfeeding (n = 343) 12.0% 42.0% 40.2% 5.8% -
Bruising and/or cephalohematoma (n = 345) 2.6% 38.6% 50.4% 8.4% -
Rh incompatibility (n = 347) 4.0% 6.9% 25.9% 61.9% 1.2%
ABO incompatibility (n = 342) 0.9% 8.8% 46.5% 43.6% 0.3%
G-6-PD deficiency (n = 339) 5.9% 17.4% 40.4% 34.2% 2.1%
Previous sibling with jaundice (n = 346) 15.6% 45.1% 34.4% 4.3% 0.6%
Pediatricians' beliefs regarding TSB levels (mg/dL) at risk for  kernicterus* Total number of respondents (University and  Community Hospitals, Private Groups and Solo Practice) Figure 3
Pediatricians' beliefs regarding TSB levels (mg/dL) at risk for 
kernicterus* Total number of respondents (University and 
Community Hospitals, Private Groups and Solo Practice).BMC Pediatrics 2006, 6:6 http://www.biomedcentral.com/1471-2431/6/6
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The majority of respondents reported using cephalocau-
dal progression of jaundice to quantify the severity despite
the inaccuracy of this methodology especially in darkly
pigmented infants [2,17]. The low utilization of TcB for
assessment of the severity of neonatal hyperbilirubinemia
that was reported by the majority of pediatricians may
reflect their uncertainty regarding the diagnostic accuracy
of this methodology [18-22] or the cost of the equipment.
It is possible that the disagreement that exists in the liter-
ature [23-29] alters the practicing pediatricians' percep-
tion regarding the importance of some significant risk
factors in the development of severe hyperbilirubinemia.
Certain aspects of our study such as the response rate of
49.1%, may limit the interpretation of the results. How-
ever, this response rate may actually represent a higher
proportion of the general pediatricians because the mail-
ing list of the New Jersey Chapter of the AAP included
pediatricians who were in specialty practice and the likeli-
hood of a response from these physicians was rather
small. Moreover, studies have shown that non-responder
bias is not strongly related to the survey response rate and
therefore it is unlikely that a greater survey response rate
would have significantly altered the results [30,31]. The
demographic composition of our respondents is no differ-
ent from that of the AAP Fellows in the rest of the United
States (Table 4). Secondly, we did not review records to
confirm actual practices. However, previous studies have
shown that surveyed physicians are able to characterize
their actual practices with reasonable accuracy [32].
Thirdly, junior fellows in residency programs and family
practitioners who may provide neonatal services were not
included in the study, but that is a relatively small group.
Conclusion
In conclusion, the apparent low threshold of bilirubin
level for the pediatrician's concern regarding kernicterus
and their willingness to initiate phototherapy or exchange
transfusion at TSB levels well below those recommended
by the AAP are the most important results of this study.
The pediatricians are aware of the message regarding the
importance of preventing severe hyperbilirubinemia and
hyperbilirubinemia-related neurological complications as
articulated in the AAP guidelines published in 2004 [2].
However, the result of this survey indicates the pediatri-
cians' uncertainties about the utilization of diagnostic
approaches and risk factor identification, and their signif-
icant tendency for lower utilization of bilirubin levels
post-discharge for the initiation of phototherapy. This
suggests the need for greater education in order to pro-
mote evidence-based practices for the prevention and
management of neonatal hyperbilirubinemia and ker-
nicterus.
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